Mark For: NIASPAN™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 76428724 |
Mark Literal Elements | NIASPAN |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 116 - DOCKET CLERK 2005-11-29 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | KAREN P BECHTOLD |
Law Office Assigned | M70 |
Employee Name | CARROLL, DORITT |
2002-01-28 | Date of Use In Commerce |
2002-01-29 | Date of First Use |
2002-06-27 | Application Filed |
2003-04-18 | Abandon |
2003-05-29 | Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi |
2003-05-29 | Status: Dead/Abandoned |
2005-11-29 | Location: TMO LAW OFFICE 116 - DOCKET CLERK |
2018-07-08 | Transaction Date |
Party: | Kos Pharmaceuticals, Inc. |
Address | 1001 Brickell Bay Drive 25th Floor Miami, FLORIDA UNITED STATES 33131 |
Legal Entity Type | Corporation |
Legal Entity State | FLORIDA |
Application | 2002-06-27 | |
Drawing | 2002-06-27 | |
Specimen | 2002-06-27 | |
Notice of Abandonment | 2003-05-29 | |
Paper Correspondence Incoming | 2005-11-14 |
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparation for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, and respiratory and infectious diseases. FIRST USE: 20020129. FIRST USE IN COMMERCE: 20020128(ABANDONED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: printed materials, namely, brochures, pamphlets, leaflets, booklets, mailings and print advertisements in publications/magazines, featuring health information about and treatments for lipid disorders, arteriosclerosis, and cardiovascular diseases. FIRST USE: 20020129. FIRST USE IN COMMERCE: 20020128
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
Type Code | Type |
---|---|
GS0051 | pharmaceutical preparation for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, and respiratory and infectious diseases |
Description | Date | Proceeding Number |
---|---|---|
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2005-12-08 | |
PAPER RECEIVED | 2005-11-14 | |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2003-05-29 | |
NON-FINAL ACTION MAILED | 2002-10-17 | |
ASSIGNED TO EXAMINER | 2002-10-01 | |
ASSIGNED TO EXAMINER | 2002-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.